C-C2X-1002
|
27231-36-3
|
2-Mercapto-5-methylbenzimidazole
|
2-Mercapto-5-methylbenzimidazole
|
|
C8H8N2S
|
CATO
|
|
0.98
|
100mg
|
|
960
|
|
|
|
|
|
|
|
C-C2X-1003
|
120014-07-5
|
多奈哌齐有关物质 A
|
Donepezil related compound A
|
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine
|
C24H29NO3
|
CATO
|
|
0.98
|
25mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1004
|
217-175-6
|
Ammonium thiocyanate
|
Ammonium thiocyanate
|
N\A
|
CH4N2S
|
CATO
|
|
0.99
|
1g
|
|
720
|
|
|
|
|
|
|
|
C-C2X-1005
|
88-32-4
|
2-tert-Butyl-4-hydroxyanisole
|
2-tert-Butyl-4-hydroxyanisole
|
2-tert-Butyl-4-hydroxyanisole
|
C11H16O2
|
CATO
|
|
0.99
|
50g
|
|
960
|
|
|
|
|
|
|
|
C-C2X-1006
|
121-00-6
|
3-tert-Butyl-4-hydroxyanisole
|
3-tert-Butyl-4-hydroxyanisole
|
3-TERT-BUTYL-4-HYDROXYANISOLE
|
C11H16O2
|
CATO
|
|
0.99
|
50g
|
|
960
|
|
|
|
|
|
|
|
C-C2X-1007
|
30845-11-5
|
S-(3-Carboxypropyl)-L-cysteine
|
S-(3-Carboxypropyl)-L-cysteine
|
(R)-4-[(2-Amino-2-carboxyethyl)thio]butanoic Acid
|
207.25
|
CATO
|
|
0.96
|
50mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1008
|
68074-89-5
|
Butanoic acid,4-[(2-amino-2-carboxyethyl)sulfinyl]-,(s)-(9Cl)
|
Butanoic acid,4-[(2-amino-2-carboxyethyl)sulfinyl]-,(s)-(9Cl)
|
C7H13NO5S
|
CATO
|
|
0.97
|
50mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1009
|
636-58-8
|
谷胱甘肽
|
glutathione
|
|
C8H14N2O5S
|
CATO
|
|
0.97
|
50mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1010
|
|
谷胱甘肽杂质 A
|
glutathione impurity A
|
|
|
CATO
|
|
0.97
|
25mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1011
|
|
谷胱甘肽杂质 B
|
glutathione impurity B
|
|
|
CATO
|
|
0.97
|
25mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1012
|
|
谷胱甘肽杂质 C
|
glutathione impurity C
|
|
|
CATO
|
|
0.97
|
25mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1013
|
|
谷胱甘肽杂质 D
|
glutathione impurity D
|
|
|
CATO
|
|
0.97
|
25mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1014
|
|
利培酮 cis-N-oxide杂质
|
Risperidone cis-N-oxide impurity
|
(cis-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl
|
C23H27FN4O3
|
CATO
|
|
0.98
|
50mg
|
|
18000
|
|
|
|
|
|
|
|
C-C2X-1015
|
|
利培酮 trans-N-oxide杂质
|
Risperidone trans-N-oxide impurity
|
(trans-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]et
|
C23H27FN4O3
|
CATO
|
|
0.98
|
50mg
|
|
18000
|
|
|
|
|
|
|
|
C-C2X-1016
|
176219-04-8
|
埃索美拉唑杂质 E
|
Esomeprazole impurity E
|
1H-Benzimidazole,5-methoxy-2-[[(4-methoxy-3,5-dimethyl-1-oxido-2-pyridinyl)methyl]sulfinyl]-(9CI)
|
C17H19N3O4S
|
CATO
|
|
0.97
|
100mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1017
|
37052-78-1
|
埃索美拉唑杂质 A
|
Esomeprazole impurity A
|
5-Methoxy-2-benzimidazolethiol
|
C8H8N2OS
|
CATO
|
|
0.97
|
100mg
|
|
1800
|
|
|
|
|
|
|
|
C-C2X-1018
|
110374-16-8
|
埃索美拉唑杂质 B
|
Esomeprazole impurity B
|
5-METHOXY-2-[(3,5-DIMETHYL-2-PYRIDINYL)-METHYLSULFINYL]-BENZIMIDAZOLE
|
C16H17N3O2S
|
CATO
|
|
0.97
|
100mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1019
|
73590-85-9
|
埃索美拉唑杂质 C
|
Esomeprazole impurity C
|
2-{[(3,5-Dimethyl-4-methoxy-2-pyridinyl)-methyl]-thio}-5-methoxy-1H-benzimidazole
|
C17H19N3O2S
|
CATO
|
|
0.97
|
100mg
|
|
3600
|
|
|
|
|
|
|
|
C-C2X-1020
|
88546-55-8
|
埃索美拉唑杂质 D
|
Esomeprazole impurity D
|
Omeprazole sulphone
|
C17H19N3O4S
|
CATO
|
|
0.97
|
100mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1021
|
73590-58-6
|
埃索美拉唑杂质 F
|
Esomeprazole impurity F
|
5-Methoxy-2-[(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-3H-benzoimidazole
|
C17H19N3O3S
|
CATO
|
|
0.97
|
100mg
|
|
1800
|
|
|
|
|
|
|
|
C-C2X-1022
|
863029-89-4
|
埃索美拉唑杂质 H
|
Esomeprazole impurity H
|
1H-Benzimidazole,2-[[(4-chloro-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-5-methoxy- (9CI)
|
C16H16ClN3O2S
|
CATO
|
|
0.97
|
100mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1023
|
158812-85-2
|
埃索美拉唑杂质 I
|
Esomeprazole impurity I
|
4-Methoxy-2-[[5-Methoxy-1H-enziMidazol-2-l]sulfonl]Methyl]-3,5-diMenthlpridine 1-oxidepyridinyl)methyl]sulfonyl]-(9CI)
|
C17H19N3O5S
|
CATO
|
|
0.97
|
100mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1024
|
|
地拉罗司杂质 D
|
Deferasirox impurity D
|
|
|
CATO
|
|
0.97
|
50mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1025
|
|
地拉罗司杂质 C
|
Deferasirox impurity C
|
|
C14H11NO4
|
CATO
|
|
0.97
|
50mg
|
|
9600
|
|
|
|
|
|
|
|
C-C2X-1026
|
99665-00-6
|
头孢呋辛杂质 B
|
Cefuroxime impurity B
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
C15H18F2N6O7S2
|
CATO
|
|
0.965
|
250mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1027
|
57658-36-3
|
5-Mercaptotetrazole-1-acetic acid
|
5-Mercaptotetrazole-1-acetic acid
|
MTAA
|
C3H4N4O2S
|
CATO
|
|
>95%
|
5g
|
|
960
|
|
|
|
|
|
|
|
C-C2X-1028
|
541-14-0
|
D(+)肉碱
|
D(+)-Carnitine
|
|
C7H15NO3
|
CATO
|
|
0.97
|
1g
|
|
1320
|
|
|
|
|
|
|
|
C-C2X-1029
|
|
头孢呋辛杂质 A
|
Cefuroxime impurity A
|
(6R,7R)-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (descarbamoylcefuroxime)
|
CATO
|
|
>95%
|
20mg
|
|
11400
|
|
|
|
|
|
|
|
C-C2X-1030
|
|
氟氧头孢
|
Flomoxef
|
(-)-(6R,7R)-7-(2-((Difluoromethyl)thio)acetamido)-3-(((1-(2-hydroxyethyl)-1H-tetrazol-5-yl)thio)methyl)-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
250mg
|
|
3600
|
|
|
|
|
|
|
|
C-C2X-1031
|
|
头孢呋辛杂质 C
|
Cefuroxime impurity C
|
(6R,7R)-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
20mg
|
|
14400
|
|
|
|
|
|
|
|
C-C2X-1032
|
|
头孢呋辛杂质 D
|
Cefuroxime impurity D
|
(6R,7R)-7-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-3-[[[(trichloroacetyl)carbamoyl]oxy]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
20mg
|
|
14400
|
|
|
|
|
|
|
|
C-C2X-1033
|
|
头孢呋辛杂质 E
|
Cefuroxime impurity E
|
(6R,7R)-3-[(carbamoyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (trans-cefuroxime)
|
CATO
|
|
>95%
|
20mg
|
|
36000
|
|
|
|
|
|
|
|
C-C2X-1034
|
|
头孢呋辛杂质 F
|
Cefuroxime impurity F
|
(6R,7R)-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
20mg
|
|
36000
|
|
|
|
|
|
|
|
C-C2X-1035
|
|
头孢呋辛杂质 G
|
Cefuroxime impurity G
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
20mg
|
|
36000
|
|
|
|
|
|
|
|
C-C2X-1036
|
|
头孢呋辛杂质 H
|
Cefuroxime impurity H
|
(5aR,6R)-6-[[(Z)-(furan-2-yl)(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione
|
CATO
|
|
>95%
|
20mg
|
|
10800
|
|
|
|
|
|
|
|
C-C2X-1037
|
|
头孢呋辛杂质 I
|
Cefuroxime impurity I
|
(Z)-(furan-2-yl)(methoxyimino)acetic acid
|
CATO
|
|
>95%
|
20mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1038
|
|
埃索美拉唑e杂质 H215
|
Esomeprazolee impurity H215
|
2-[[(5-hydroxy-1H-benzimidazol-2-yl)sulfinyl] methyl]-3,5-dimethy-1-4(1H)-pyridone
|
CATO
|
|
>95%
|
50mg
|
|
12000
|
|
|
|
|
|
|
|
C-CDF-1001
|
92823-03-5
|
氟氧头孢 sodium
|
Flomoxef sodium
|
|
C15H17F2N6NaO7S2
|
CATO
|
|
>95%
|
250mg
|
|
6000
|
|
|
|
|
|
|
|
C-C2X-1039
|
|
头孢哌酮
|
Cefoperazone
|
(6R,7R)-7-{[(2S)-2-{[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino}-2-(4-hydroxyphenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbo xylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1040
|
|
头孢哌酮杂质 A
|
Cefoperazone Impurity A
|
(5aR,6R)-6-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1041
|
|
头孢哌酮杂质 B
|
Cefoperazone Impurity B
|
(6R,7R)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(4-methyl-5-thioxo-4,5-dihydro-1H-tetrazol-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1042
|
|
头孢哌酮 杂质 C
|
Cefoperazone Impurity C
|
1-methyl-1H-tetrazole-5-thiol
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1043
|
|
头孢哌酮杂质 D
|
Cefoperazone Impurity D
|
(6R,7R)-7-amino-8-oxo-3-[(1H-1,2,3-triazol-4-ylsulphanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-TACA)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1044
|
|
头孢哌酮杂质 E
|
Cefoperazone Impurity E
|
(6R,7R)-3-[(acetyloxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1045
|
|
头孢哌酮 杂质 F
|
Cefoperazone Impurity F
|
(6R,7S)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxopiperazine-1-yl)carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1046
|
|
头孢他啶
|
ceftazidime
|
(6R,7R)-7-[(3Z)-3-(2-Amino-1,3-thiazol-4-yl)-3-{[(2-carboxy-2-propanyl)oxy]imino}-2-oxopropyl]-8-oxo-3-(1-pyridiniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1047
|
|
头孢他啶杂质 A
|
ceftazidime impurity A
|
(2RS,6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate (Δ-2-ceftazidime)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1048
|
|
头孢他啶杂质 B
|
ceftazidime impurity B
|
(6R,7R)-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1049
|
|
头孢他啶杂质 C
|
ceftazidime impurity C
|
(6R,7R)-7-amino-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1050
|
|
头孢他啶杂质 E
|
ceftazidime impurity E
|
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1051
|
|
头孢他啶杂质 F
|
ceftazidime impurity F
|
Pyridine
|
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1052
|
|
头孢他啶杂质 G
|
ceftazidime impurity G
|
2-[[[(1Z)-1-(2-aminothiazol-4-yl)-2-[(oxoethyl)amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1053
|
|
头孢他啶杂质 H
|
ceftazidime impurity H
|
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-[(2-methoxy-1,1-dimethyl-2-oxoethoxy)imino]acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1054
|
|
头孢克肟
|
Cefixime
|
(6R,7R)-7-({(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl}amino)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1055
|
|
头孢克肟杂质 A
|
Cefixime impurity A
|
2-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-2-[(2R)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]acetic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1056
|
|
头孢克肟杂质 B
|
Cefixime impurity B
|
2-[[[(Z)-1-(2-aminothiazol-4-yl)-2-[[[(2R,5RS)-5-methyl-7-oxo-1,2,5,7-tetrahydro-4H-furo[3,4-d][1,3]thiazin-2-yl]methyl]amino]-2-oxoethylidene]amino]oxy]acetic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1057
|
|
头孢克肟杂质 C
|
Cefixime impurity C
|
(6R,7S)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cefixime 7-epimer)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1058
|
|
头孢克肟杂质 D
|
Cefixime impurity D
|
(6R,7R)-7-[[(E)-2-(2-aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cefixime E-isomer)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1059
|
|
头孢克肟杂质 E
|
Cefixime impurity E
|
(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1060
|
|
头孢克肟杂质 F
|
Cefixime impurity F
|
(6R,7R)-7-[[(Z)-2-(2-aminothiazol-4-yl)-2-[(2-ethoxy-2-oxoethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1061
|
|
头孢曲松
|
CEFATRIAXONE
|
7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxyli c acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1062
|
|
头孢曲松杂质 A
|
CEFATRIAXONE Impurity A
|
(6R,7R)-7-[[(2E)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ((E)-isomer)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1063
|
|
头孢曲松杂质 B
|
CEFATRIAXONE Impurity B
|
(5aR,6R)-6-[[(2Z)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1064
|
|
头孢曲松杂质 C
|
CEFATRIAXONE Impurity C
|
2-methyl-3-sulphanyl-1,2-dihydro-1,2,4-triazine-5,6-dione
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1065
|
|
头孢曲松杂质 D
|
CEFATRIAXONE Impurity D
|
S-benzothiazol-2-yl (2Z)-(2-aminothiazol-4-yl)(methoxyimino)thioacetate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1066
|
|
头孢曲松杂质 E
|
CEFATRIAXONE Impurity E
|
(6R,7R)-7-amino-3-[[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulphanyl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1067
|
|
头孢克洛
|
cefaclor
|
(6R,7R)-7-{[(2R)-2-Amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1068
|
|
头孢克洛杂质 A
|
cefaclor impurity A
|
(2R)-2-amino-2-phenylacetic acid (phenylglycine)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1069
|
|
头孢克洛杂质 B
|
cefaclor impurity B
|
(6R,7R)-7-amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1070
|
|
头孢克洛杂质 C
|
cefaclor impurity C
|
(6R,7R)-7-[[(2S)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1071
|
|
头孢克洛杂质 D
|
cefaclor impurity D
|
(2R,6R,7R)- and (2S,6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid (delta-3-cefaclor)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1072
|
|
头孢克洛杂质 E
|
cefaclor impurity E
|
2-[[(2R)-2-amino-2-phenylacetyl]amino]-2-(5-chloro-4-oxo-3,4-dihydro-2H-1,3-thiazin-2-yl)acetic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1073
|
|
头孢克洛杂质 F
|
cefaclor impurity F
|
3-phenylpyrazin-2-ol
|
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1074
|
|
头孢克洛杂质 G
|
cefaclor impurity G
|
(2R,6R,7R)- and (2S,6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methylene-8-oxo-5-thia-1-azabicyclo[4.2.0]octane-2-carboxylic acid (isocefalexine)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1075
|
|
头孢克洛杂质 H
|
cefaclor impurity H
|
(6R,7R)-7-[[(2R)-2-[[(2R)-2-amino-2-phenylacetyl]amino]-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (N-phenylglycyl cefaclor)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1076
|
|
头孢吡肟
|
cefepime
|
(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methyl-1-pyrrolidiniumyl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1077
|
|
头孢吡肟杂质 A
|
cefepime impurity A
|
(6R,7R)-7-[[(2E)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (anti-cefepime)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1078
|
|
头孢吡肟杂质 B
|
cefepime impurity B
|
(6R,7R)-7-[[(2Z)-[2-[[(2Z)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]thiazol-4-yl](methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1079
|
|
头孢吡肟杂质 C
|
cefepime impurity C
|
(2Z)-2-(2-aminothiazol-4-yl)-N-(formylmethyl)-2-(methoxyimino)acetamide
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1080
|
|
头孢吡肟杂质 D
|
cefepime impurity D
|
(2Z)-(2-aminothiazol-4-yl)(methoxyimino)acetic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1081
|
|
头孢吡肟杂质 E
|
cefepime impurity E
|
(6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1082
|
|
头孢吡肟杂质 F
|
cefepime impurity F
|
(6R,7R)-7-[[[(6R,7R)-7-[[(2Z)-(2-aminothiazol-4-yl)(methoxyimino)acetyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]carbonyl]amino]-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1083
|
|
头孢吡肟杂质 G
|
cefepime impurity G
|
N-methylpyrrolidine
|
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1084
|
|
头孢噻肟杂质 A
|
cefotaxime Impurity A
|
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (deacetoxycefotaxime)
|
CATO
|
|
>95%
|
50mg
|
|
33600
|
|
|
|
|
|
|
|
C-C2X-1085
|
|
头孢噻肟杂质 B
|
cefotaxime Impurity B
|
(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (deacetylcefotaxime)
|
CATO
|
|
>95%
|
50mg
|
|
33600
|
|
|
|
|
|
|
|
C-C2X-1086
|
|
头孢噻肟杂质 C
|
cefotaxime Impurity C
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-[2-(formylamino)thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (N-formylcefotaxime)
|
CATO
|
|
>95%
|
50mg
|
|
42000
|
|
|
|
|
|
|
|
C-C2X-1087
|
|
头孢噻肟杂质 D
|
cefotaxime Impurity D
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (E-cefotaxime)
|
CATO
|
|
>95%
|
50mg
|
|
42000
|
|
|
|
|
|
|
|
C-C2X-1088
|
|
头孢噻肟杂质 E
|
cefotaxime Impurity E
|
(5aR,6R)-6-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione (deacetylcefotaxime lactone)
|
CATO
|
|
>95%
|
50mg
|
|
33600
|
|
|
|
|
|
|
|
C-C2X-1089
|
|
头孢噻肟杂质 F
|
cefotaxime Impurity F
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-[2-[[[(6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-2-yl]methyl]amino]thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (cefotaxime dimer)
|
CATO
|
|
>95%
|
50mg
|
|
42000
|
|
|
|
|
|
|
|
C-C2X-1090
|
|
头孢噻肟杂质 G
|
cefotaxime Impurity G
|
(6R,7R)-3-[(acetyloxy)methyl]-7-[[(2Z)-2-[2-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]thiazol-4-yl]-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (ATA cefotaxime)
|
CATO
|
|
>95%
|
50mg
|
|
42000
|
|
|
|
|
|
|
|
C-C2X-1091
|
|
头孢西丁
|
cefoxitin
|
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1092
|
|
头孢西丁杂质 A
|
cefoxitin impurity A
|
(6R,7S)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (decarbamoylcefoxitin)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1093
|
|
头孢西丁杂质 B
|
cefoxitin impurity B
|
(2RS,6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[[(thiophen-2-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid (delta-3-cefoxitin)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1094
|
|
头孢西丁杂质 C
|
cefoxitin impurity C
|
(5aR,6R)-6-[[(thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione (cefalotin lactone)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1095
|
|
头孢西丁杂质 D
|
cefoxitin impurity D
|
(5aR,6S)-6-methoxy-6-[[(thiophen-2-yl)acetyl]amino]-5a,6-dihydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazine-1,7(4H)-dione (cefoxitin lactone)
|
CATO
|
|
>95%
|
|
|
0
|
|
|
|
|
|
|
|
C-C2X-1096
|
41100-45-2
|
3-ethyladamantan-1-amine
|
3-ethyladamantan-1-amine
|
|
C12H21N
|
CATO
|
|
>95%
|
100mg
|
|
3600
|
|
|
|
|
|
|
|
C-C2X-1097
|
|
硼替佐米杂质 A
|
bortezomib impurity A
|
|
C14H14N4O2
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1098
|
|
硼替佐米杂质 C
|
bortezomib impurity C
|
|
C19H25BN4O4
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1099
|
|
硼替佐米杂质 E
|
bortezomib impurity E
|
|
C19H24N4O3
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1100
|
|
硼替佐米杂质 F
|
bortezomib impurity F
|
|
C15H15N3O3
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1101
|
|
硼替佐米杂质 G
|
bortezomib impurity G
|
|
C19H24N4O3
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1102
|
|
硼替佐米杂质 H
|
bortezomib impurity H
|
|
C15H15N3O3
|
CATO
|
|
>95%
|
20mg
|
|
7200
|
|
|
|
|
|
|
|
C-C2X-1103
|
62833-66-3
|
奥拉西坦杂质 II
|
Oxiracetam impurity II
|
|
C6H8N2O2
|
CATO
|
|
>95%
|
20mg
|
|
4800
|
|
|
|
|
|
|
|
C-C2X-1104
|
13674-87-8
|
磷酸三(2,3-二氯丙基)酯
|
下一篇:美国CATO标准品